Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.52 |
| ▸ | LPL | P06858 | 11/20 | 0.52 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | P4HB | P07237 | 1/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.32 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29450796 | 1.00 | LIPG (0.52) | LIPGLPLIRAK4P4HBMTNR1A | |
| SCHEMBL17878483 | 1.00 | LIPG (0.52) | LIPGLPLIRAK4P4HBMTNR1A | |
| SCHEMBL29450797 | 1.00 | LIPG (0.52) | LIPGLPLIRAK4P4HBMTNR1A | |
| SCHEMBL17878499 | 0.93 | LIPG (0.57) | LIPGLPLIRAK4P4HBDGAT1 | |
| SCHEMBL17878489 | 0.92 | LIPG (0.54) | LIPGLPLIRAK4P4HBMTNR1A | |
| SCHEMBL16282225 | 0.92 | LIPG (0.62) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL15553523 | 0.92 | LIPG (0.49) | LIPGLPLIRAK4P4HBKDM4E | |
| SCHEMBL28951694 | 0.91 | LIPG (0.64) | LIPGLPLIRAK4DGAT1KDM4E | |
| SCHEMBL31672314 | 0.90 | LIPG (0.52) | LIPGLPLIRAK4P4HBDGAT1 | |
| SCHEMBL14414379 | 0.90 | LIPG (0.52) | LIPGLPLIRAK4P4HBDGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114144402-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-02-27 | — | — | CN | disclosed |
| CN-114144402-A | Novel compound and organic light emitting device comprising same | 株式会社LG化学 | 2022-03-04 | — | — | CN | disclosed |
| US-9957441-B2 | Amine-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-9957441-B2 | Amine-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-20160190467-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160190467-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160190467-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | AOC2, TYR, TAAR1 | LIPG 3199/4885LPL 2918/4885IRAK4 2955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.